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Objective: This study was conducted to determine the prevalence of renal artery stenosis (RAS) among patients referred to
a vascular laboratory in a university hospital, to identify those who are possible candidates for revascularization, and to
determine the prevalence of other pathologies incidentally detected.
Methods: Consecutive patients referred to our laboratory for exclusion of RAS were included. Color duplex ultrasound
(DU) imaging of the abdominal aorta, renal vasculature, and kidney parenchyma was performed. The resistivity index of
the kidney (RI) was measured, and 0.8 was used as a cutoff to identify those with severe kidney disease that could be
excluded from an intervention. Incidental findings were also noted.
Results: A total of 324 patients were included from September 1998 to August 2003. Unilateral RAS was found in 14%
and bilateral in 7%. Unilateral (1.5%) and bilateral (0.6%) renal artery occlusions were rare. The main reason for referral
was uncontrolled (43%) and controlled hypertension (34%). Most patients (63%) were taking two or more antihyper-
tensive drugs. The diagnostic yield was 22% among those using two drugs and 55% among those using three or more. In
46 patients (64%), the RI was <0.8. Seven cases of fibromuscular dysplasia were found (10% of RAS patients or 2%
overall). Incidental findings were detected in 24% and were significant enough to alter management in 26% among those
with such findings.
Conclusions:Our study identified a RAS prevalence of 22% and a renal artery occlusion prevalence of 4%. There was a high
yield for RAS in patients receiving three or more drugs; however, the yield was also significant among those receiving two
or more. About two thirds of patients diagnosed with RAS were potential revascularization candidates, evidenced by a
low RI. DU imaging is also very useful in detecting pathology that is significant to alter patients’ management. (J Vasc
Surg 2007;46:731-7.)Renovascular disease due to atherosclerosis or fibro-
muscular dysplasia (FMD) is the most common cause of
secondary hypertension.1 Its prevalence in the general
population has not been appropriately identified. One
population-based study reported a 7% prevalence in peo-
ple aged 65 years.2 Among Americans with hyperten-
sion, it has been calculated to be up to 5%.3
Renovascular hypertension results from a lesion of the
renal artery, and it is relieved either by correction of the
lesion or by removal of the kidney.4 Renal artery stenosis
(RAS) represents the most common cause of correctable
hypertension.5 Proper screening criteria can provide early
detection for this potentially curable form of hypertension.
The “gold standard” for the diagnosis of RAS is selec-
tive arteriography, but because of its cost and invasive
nature, it is unsuitable for screening purposes. Renal duplex
ultrasound (DU) imaging performed by skilled operators in
experienced laboratories obtained sensitivities, specificities,
positive and negative predictive values, and overall accuracy
of 90% for identification of renovascular disease.5-8 It
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doi:10.1016/j.jvs.2007.05.058assesses the renal parenchyma and predicts the outcome of
renal revascularization. DU imaging is arguably considered
to be the best screening test for RAS.9 In addition, it can
detect other pathologies incidentally such as abdominal
aortic aneurysms (AAA) and tumors that may change the
patient’s management. DU imaging also provides key in-
formation about the renal function and its natural history
by measuring the resistivity index (RI) of the kidney in its
segmental arteries.10
This study aimed to determine the prevalence of pa-
tients with RAS, to identify those patients who are possibly
ideal candidates for percutaneous transluminal renal angio-
plasty and stenting (PTRAS) by showing a RI of0.8, and
to determine the prevalence of other pathologies that were
incidentally detected.
METHODS
Consecutive patients referred to our vascular laboratory
at Loyola University Medical Center in Maywood, Illinois,
to assess renovascular pathology were included in the study.
Reasons for referral in most patients included any of the
following, alone or in combination: acute onset, malignant,
or accelerated hypertension; epigastric bruit; azotemia in
the presence of an angiotensin-converting enzyme inhibi-
tor; unilateral small kidney; unexplained deterioration in
renal function; uncontrolled hypertension despite three or
more antihypertensive medications; and flash pulmonary
edema. Hematuria, proteinuria, or flank pain were also
other less specific reasons for referral, and were considered
only when concomitant hypertension was present.
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us so the diagnostic yield in different groups of patients
could be defined. Patients were subdivided according to
the adequacy of blood pressure control. Controlled or
uncontrolled hypertension was defined considering the
opinion of the referring physician and according to the
blood pressure readings obtained at the vascular laboratory
in the morning of the DU study. The diagnosis of hyper-
tension itself was not made in our laboratory, however. We
merely confirmed the controlled or uncontrolled nature of
the patients’ hypertension and notified the referring physi-
cians whenever the blood pressure was elevated despite
documented patient compliance with their medication.
Color DU imaging with a 2-MHz to 3-MHz curvilin-
ear array transducer (HDI 5000, iU22 Phillips, Bothell,
Wash) was used to evaluate the abdominal aorta, renal
vasculature, and kidney parenchyma. The examination was
performed in the morning after 10 hours of overnight
fasting. Blood pressure recordings were obtained in both
arms and the highest was recorded. The aorta was identified
at the left of the midline. The aorta was scanned from the
diaphragm until its bifurcation to detect aneurysms or
significant stenosis. The largest aortic diameter was re-
corded.
A reference aortic velocity was obtained just above the
renal arteries using the superior mesenteric artery (SMA) as
a landmark. Then, the celiac artery and SMA were imaged,
and the highest velocities from each vessel were recorded.
The aorta was followed in the transverse view, and the
left renal vein was identified. The origin of the right renal
artery was visualized at this level, and three velocity record-
ings were taken at its proximal, middle, and distal segments.
The left renal artery was identified usually a bit lower, and
the same measurements were performed. When the trans-
abdominal imaging was suboptimal, the renal arteries were
imaged through a flank approach using the lateral decubi-
tus position. The kidney length and velocity recordings
from segmental arteries were measured from the same
position.
Steering is not feasible with phased or curve-linear array
transducers. Therefore, to facilitate imaging of the renal
arteries at an angle of insonation at 0° or between 45° and
60°, longitudinal, transverse, and oblique cuts were ob-
tained in relation to the aorta. To decrease the noise
produced by the wall motion of the aorta and the visceral
vessels, a high-pass filter was used.
Examinations were categorized as incomplete when the
renal artery was not imaged in its entire length. They were
called failed when the renal artery was not seen at all.
As a part of our laboratory’s accreditation by the Inter-
societal Commission for the Accreditation of Vascular Lab-
oratories, our RAS diagnostic criteria were validated against
angiography. The cutoff for significant RASwas set at a 60%
diameter reduction. The best criteria for defining such a
stenosis in our laboratory was a peak systolic velocity (PSV)
200 cm/s and a renal aortic systolic ratio (RAR) 2.5.
Atherosclerotic lesions are more likely found in the proxi-
mal third of the renal artery as an extension of an aorticplaque. When a PSV 200 cm/s alone was used, the
sensitivity was 89% and the specificity was 83%. A RAR of
3.5 gave a sensitivity of 78% and a specificity of 90%. A RAR
of 2.5 had a sensitivity of 98% and a specificity of 86%. A
combination of PSV 200 cm/s and a RAR 2.5, gave a
sensitivity of 92% and a specificity of 94%.
Fibromuscular dysplasia (FMD) is found in the distal
two thirds of the renal artery, most often between the third
and fifth decades of life. Our own institutional criteria for
the diagnosis of FMD require at least three strings-of-bead
lesions, because two consecutive plaques can give a similar
appearance as FMD owing to poststenotic dilatations. We
specifically looked for the absence of atherosclerotic plaque
to make the diagnosis. Abnormal flow findings in FMD
include increased velocity and turbulent flow along the
stenotic and dilated areas.
Color DU imaging can be used to measure an RI from
the segmental arteries of the kidney (RI  [PSV – EDV]/
[PSV]), with EDV as the end-diastolic velocity.11 The RI
was determined with three measurements from the upper,
middle, and lower kidney. A RI 0.8 was used to identify
patients with severe parenchymal disease who could be
excluded from interventional treatment. However, the in-
tervention for RAS was dependent on criteria used from
different services. All incidental findings in the field of
imaging, such as AAA, cysts, and tumors were recorded.
Only studies that were performed in our institution and
only those in which results were confirmed by the first
author (N. L.) were included. A customized database was
constructed on Microsoft Access (Microsoft Corp, Red-
mond, Wash), and all the data were prospectively collected.
Descriptive statistics were used for the analysis of the data.
RESULTS
A total of 324 consecutive patients (169 females, 155
males) were included from September 1998 until August
2003. Their mean age was 62.9 years (range, 9 to 89 years),
and the age distribution was 2 patients (0.6%)20 years, 5
(1.5%) between 20 and 29, 17 (5.2%) between 30 and 39,
30 (9.3%) between 40 and 49, 66 (20.4%) between 50 and
59, and 204 (62.9%) were 60 years. The prevalence in
patients aged 60 was higher compared with those
younger (28% vs 17.6%; P  .044).
Examinations were failed or incomplete in 14 patients,
and 12 of these studies were repeated. Eight were com-
pleted without any problems; therefore, six patients had
incomplete examinations and are not included in the study.
Seventeen patients brought examinations to us from out-
side institutions, where RAS was seen incidentally or the
test was suboptimal. Of these cases, 12 were confirmed by
DU imaging of having the disease, four were normal, and
one was uncertain. This patient underwent an angiogram
that showed a 50% stenosis.
Renal DU imaging revealed unilateral RAS in 44 pa-
tients (13.6%), whereas bilateral cases were found in 23
(7.1%). Unilateral and bilateral RA occlusions were found
rarely, with a prevalence of 1.5% and 0.6%, respectively. The
combination of RAS and occlusion was seen in five cases
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of RAS patients and 2.2% of the total number of patients
referred for evaluation. Among those patients with unilat-
eral or bilateral RAS, uncontrolled hypertension was the
most frequent reason for referral (59.1% and 56.5%, respec-
tively; Table I). Among the 72 patients with RAS, 46
(63.9%) had an RI0.8 and were considered to be suitable
candidates for PTRAS. Incidentally, 120 patients (37%)
had an RI 0.8, indicating parenchymal disease.
A total of 88 incidental findings in 76 patients (23.5%)
were noted. Of these, 23 were significant enough to trigger
further diagnostic testing or management, as summarized
in Table II. The most common incidental finding was renal
cyst (40.9%). The length of the renal cysts was5 cm in six
cases, and three patients had evidence of polycystic kidney
disease. AAA (10.2%) and aortic stenosis (4.5%) were the
most common of the clinically significant findings.
The most common causes for patient referral were
uncontrolled (44%) and controlled hypertension (34%),
and 63% of these patients (205/324) were more often
taking two or more antihypertensive medications. Sixteen
patients (4.9%) referred for renal artery evaluation had only
atherosclerosis in other arterial trees or had symptoms
unrelated to renal pathology. In none of them RAS or
occlusion was found and their RI values were normal.
The correlation between the yield of RAS diagnosis and
the number of antihypertensive medications that patients
used at the moment of DU examination is summarized in
Table III. Among those using two drugs, the diagnostic
yield was 21.7% and it was 54.8% among those using three
or more.
DISCUSSION
Reason for referral. DU imaging is a very useful
method to screen for RAS. Digital subtraction angiography
is currently the reference standard for its diagnosis but is
unsuitable for screening. A good correlation has been re-
cently found between the diagnostic accuracy of DU imag-
Table I. Reasons for referral
N
Medications, n
3 2 1 0
Hypertension
Controlled 110 19 48 35
Uncontrolled 140 35 79 24
Acute onset 3 0 0 0
Hematuria 4 1 1 0
Proteinuria 2 0 1 0
Renal failure 23 4 8 3
Flank pain 15 3 5 4
Other 11 0 1 0
Inappropriate 16 0 0 2 1
Total 324 62 143 68 4
RAS, Renal artery stenosis; DU, duplex ultrasound; Uk, unknown; U, unila
occlusion.ing compared with angiography using both PSV200 andRAR 2.5.12 In that study, which was subsequent to our
validation data, a reduction in the PSV dramatically de-
creased the specificity of the test. Most of the literature
recommends for RAS 60%, a PSV 200 cm/s, and a
RAR of 2.5 or 3. This is particularly true when the aortic
velocity is 40cm/s or 100 cm/s.12 Identifying clinical
features of patients who are likely to have renovascular
disease is important because its prevalence is not large
enough to allow population-based screening. Screening
must therefore be precise and use specific criteria.13
Obesity made the DU examination more difficult, par-
ticularly in patients with a body mass index (BMI) 40.
However, most of the failures were early in our study.
RAS detected by DU imaging
Uk U B UO BO RASO
2 11 4 3 0 2
2 26 13 1 1 3
1 0 0 0 0
0 1 1 0 0
0 0 0 0 0
0 3 1 0 1
0 1 4 1 0
2 2 0 0 0
4 0 0 0 0
11 44 23 5 2 5
14% 7% 2% 1% 2%
AS; B, bilateral RAS; O, occlusion; UO, unilateral occlusion; BO, bilateral
Table II. Incidental findings
Finding N Incidental findings, %
Abdominal aortic aneurysm* 9 10
Aortic stenosis* 4 5
Celiac artery stenosis 7 8
SMA stenosis 7 8
Renal artery aneurysm* 1 1
SMV thrombosis* 1 1
Renal vein thrombosis* 2 2
Retroaortic left renal vein 1 1
Renal cell cancer* 3 3
Renal cysts 36 41
Renal stones 6 7
Paradoxical kidney length 3 3
Solitary kidney 1 1
Horseshoe kidney 1 1
Pelvic kidney 1 1
Hydronephrosis* 1 1
Inflammation 2 2
Ureteral obstruction* 1 1
Neurofibromatosis* 1 1
Total 88 100
SMA, Superior mesenteric artery; SMV, superior mesenteric vein.
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evaluation. We had a few patients with a BMI30 but very
few with a BMI40.Morbidly obese patients are definitely
a challenge for DU imaging and also for any other diagnos-
tic test.
We have determined from our experience and the re-
ported literature that patients who are appropriate for DU
screening referral are those with acute onset or malignant
hypertension, epigastric bruit, azotemia in the presence of
an angiotensin-converting enzyme inhibitor, unilateral
small kidney, unexplained deterioration in renal function,
and flash pulmonary edema. Uncontrolled hypertension
despite more than two appropriate antihypertensive drugs
should also be an appropriate reason for referral given the
high yield of positive results in this study subgroup.
Prevalence of disease. The prevalence of renovascu-
lar disease has not been clearly defined, varying accord-
ing to the population studied.3 In the first prospective,
population-based study in the general population, reno-
vascular disease was detected in 6.8% of people aged 65
years.2 Most of the published work, however, includes
patients having risk factors for this disease, such as hyper-
tension or renal dysfunction, or are performed on autopsy
series of patients who died in the hospital, where atheroscle-
rosis is likely to be a contributor to the cause of death. It is
found in 17% to 43% of appropriately screened patients re-
ferred to subspecialty centers for severe hypertension.14,15
Autopsy studies revealed a prevalence of 18% for patients
between the ages of 64 and 75 and 42% for patients75 years
old. Atherosclerotic renal artery lesionsweremost often found
in patients aged50 years old.Nonatherosclerotic conditions
were most often found in younger patients.
The age distribution of the patients in our study
showed an increasing occurrence of RAS with increasing
age. Angiographic studies reported a prevalence of 11% to
42%, greater in patients with systemic atherosclerosis.3,16
We found a RAS prevalence of 22.2% and a renal artery
occlusion prevalence of 3.7% detected byDU imaging. Our
population also included patients who were hospitalized,
where the prevalence of atherosclerosis is significant, likely
accounting for the high prevalence of RAS found. Further-
more, we included patients referred from our Veterans
Table III. Number of antihypertensive medications and d
Patients, n 3
Unilateral RAS 44 1
Bilateral RAS 23 1
Unilateral occlusion 5
Bilateral occlusion 2
RAS  Occlusion 5
Total 79 3
Total (of referred patients) 324 6
Diagnostic yield (%) 24 5
Uk, Unknown; RAS, renal artery stenosis.Affairs Hospital. These patients are thought to have moreatherosclerotic risk factors and therefore a higher chance to
develop RAS.
Our prevalence rates can also be underestimated owing
to the presence of accessory renal vessels, which have been
reported in at least 15% to 17% of kidneys.17 Isolated
accessory RAS with patent main renal arteries can produce
renovascular hypertension. DU imaging does not reliably
identify accessory kidney vessels, as was shown in the work
by Halpern et al,18 where computed tomography angiog-
raphy was superior in its detection.
The occurrence of hemodynamically significant steno-
sis isolated to an accessory renal artery has been calculated
in 1.5% in a retrospective review of renal angiograms of
patients who underwent workup for renovascular hyperten-
sion.17 Renal accessory vessels were present in 15 (17%) of
87 kidneys that were found to have hemodynamically sig-
nificant stenoses by pressure gradient in 42 patients or by
lumen narrowing in 22. Only one of 68 patients was
diagnosed with a hemodynamically significant accessory
stenosis associated with bilateral normal main renal arteries,
which was treated with angioplasty. Concomitant main and
accessory RAS were seen in two (2.9%) of the 68 patients.
One of them was ipsilateral, and the other had main RAS
and bilateral accessory arteries, one with stenosis.
Our prevalence, although higher than previously re-
ported, may therefore reflect more accurately the expected
prevalence of RAS and occlusion in an accredited and
experienced vascular laboratory of a university hospital.
Fibromuscular dysplasia. FMD is commonly seen in
young patients, particularly white women between the ages
of 30 and 50. In children, FMD may be associated with
neurofibromatosis or abdominal aortic coarctation.19 FMD
tends to occur bilaterally and affects the distal two thirds of
the renal artery.1 In contrast, atherosclerotic RAS usually
occurs in older patients, often involving the proximal third
of the renal artery.1 In our analysis, we found seven cases of
FMD among the 72 RAS patients, which represented 9.7%
of RAS patients. Our results correlate with the 10% preva-
lence of FMD within the RAS population reported by
Safian and Textor.1
Resistivity index and prediction of success after
intervention. A significantly reduced diastolic flow com-
ostic yield for renal artery stenosis
Medications, n
2 1 0 Uk
20 5 4 0
7 3 0 0
3 0 1 0
0 0 0 0
1 1 0 0
31 9 5 0
143 68 40 11
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measures the impedance within the kidney parenchyma and
provides valuable information to direct management of the
patient.11 Radermacher et al10 showed that 96 (73%) of
138 RAS patients had a RI0.8, and 90 (94%) exhibited a
successful decrease in blood pressure by at least 10% after
angioplasty was performed. If a RAS patient has a RI0.8,
angioplasty or surgery often fails to improve renal function,
blood pressure, or kidney survival. Improving perfusion to
an already damaged organ is likely futile; therefore RAS
patients with a low RI are good candidates for PTRAS. Our
study showed that 46 (63.9%) of 72 patients with RAS had
a RI 0.8 and were referred for evaluation as possible
PTRAS candidates. An RI of 0.8 was a good indication
for failure for intervention in our series. In fact, only two of
our patients with an RI of 0.8 and 0.82 reduced the number
of medications from three to two and from four to three,
respectively. When the RI was0.85 no patient improved,
but a few became worst. A detailed study of our results
based on RI is underway.
Recently, the value of RI has been challenged. Zeller
et al20 analyzed a 5-year, single-center experience with
renal artery angioplasty. They identified a benefit of
intervention even with RI levels 0.8. Several criticisms
can be made to the design of their study. Even though
their criteria for inclusion are not specified, baseline
creatinine and mean arterial blood pressure levels are
those of mild renal dysfunction. There is no mention of
prior attempts for blood pressure control with medical
therapy. They probably did not meet standard accepted
criteria for renovascular intervention. Also, the improve-
ment obtained with intervention in those parameters,
even though statistically significant, is small and likely of
very low clinical impact.
Although RI has been shown to be a good predictor for
success after intervention, it is also conceivable that revas-
cularization would be important to prolong the life of the
kidney and delay time for dialysis. Others have tested other
predictors with different success. Recently, Voiculescu et
al21 prospectively tested RI and measurements of renal
vein/plasma renin activity, finding that an RI 0.55 and a
renin ratio of 1:1.5 correlated with poor outcomes after
revascularization for unilateral RAS.
We believe that because there is a controversy in the use
of RI as the sole criteria for intervention, other factors
should be taken into account for intervening in such pa-
tients, particularly when the prolongation of the time to
dialysis has not been resolved yet, regardless of the effect of
the intervention for the treatment of hypertension.
There is an interesting, well-established relationship
between hypertension and parenchymal disease. Primary
parenchymal disease may cause secondary hypertension, or
conversely, systemic hypertension may damage the kidney
parenchyma. Accordingly, a primary unilateral asymptom-
atic RAS can cause secondary parenchymal injury to the
contralateral kidney. Apparently, the ipsilateral kidney is
protected by the stenosis, but the contralateral kidney is
susceptible to damage by the systemic hypertension.22 Ofinterest is that three RAS patients studied at our institution
exhibited paradoxical small kidney length on the contralat-
eral side due to this phenomenon.
Number of antihypertensive medications and renal
artery stenosis. It has been said that failure to achieve
blood pressure control after an optimal length of therapy
with adequate doses of three types of antihypertensive
medication suggests RAS.23 This has been assumed owing
to the impression that patients using fewer than three drugs
can be easily managed medically. There are no available
data in the literature to support such a widely used tenet.
Our analysis revealed that patients taking three or more
antihypertensive drugs had a diagnostic yield of 54.8%, but
patients taking two drugs had a yield of 21.7%. Raderma-
cher and Brunkhorst reported clinical clues suggestive of
RAS based on a preselected population of 1198 subjects
with a RAS prevalence of 21% (unpublished data), similar
to that of the present study. A relative risk of 2.52 of RAS in
the presence of lack of blood pressure control with three
drugs was found.24 The large number of confounding
variables in this matter makes the acceptance of valid con-
clusions difficult. Factors such as drug interactions or
choice of medications that are not optimal according to a
particular patient are not routinely considered in this anal-
ysis. Therefore, RAS screening may be warranted in those
patients who are taking two or more well-selected antihy-
pertensive medications, given the high likelihood of a pos-
itive diagnosis that was found in this subgroup of subjects.
Incidental findings. Beyond examination of the renal
vessels, DU imaging may also detect additional useful
information about the kidney itself and the surrounding
structures. Incidental findings during DU examination of
different body areas have been extensively studied. Keyser-
ling et al,25 in a retrospective design, evaluated DU imag-
ing of patients with renal failure in the intensive care unit
setting. They identified incidental findings in 91 patients
out of 105 scans reviewed, although most of the findings in
that study were irrelevant and nonspecific for the patient’s
condition. Two renal masses were found that could have
potentially changed the management of those patients.
Helke et al26 reviewed 19,700 DU studies of the epi-
gastrium of adult patients. Independently of the question-
ing of the referring physician, the kidneys were involved in
the examination. They found malignant renal lesions in 80
cases (0.4%), with 30 never suspected to have a tumor. The
better prognosis of incidentally detected renal carcinomas
compared with the symptomatic ones26,27 and the number
of incidental findings led them to suggest a simultaneous
examination of the kidneys in each abdominal DU scan,
independent of the actual indication.
Our study revealed 88 incidental findings (23.5%) in 76
patients. Of these findings, 26.1% (23/88) had an impact
on the particular management of the patient (Table III).
AAA were found in almost 3% of the studied population
that represented about 10% of all detected incidental find-
ings. This finding led to aneurysm repair or follow-up,
depending on the size and clinical condition of the patient.
Localized aortic stenosis was found in about 1% of the
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cause of clinical significant incidental findings diagnosed by
DU imaging. This finding mandates as a minimum further
questioning about pelvic and lower extremity symptoms,
hemodynamic testing or imaging, or both, to evaluate its
clinical significance, with subsequent observation or inter-
vention.
Thrombosis of the renal vein was uncommon, found in
only 0.6% of patients screened, but the clinical meaning of
this finding is potentially significant. Malignancy should be
considered in the differential diagnosis of a patient with
apparent spontaneous thrombosis, possibly due to a hyper-
coagulable state secondary to a paraneoplastic syndrome.
One child screened for high blood pressure was found
to have neurofibromatosis. Neurofibromatosis type 1 may
be associated with vascular lesions, and they may involve
the renal arteries, leading to hypertension. In a study by
Fossali et al,28 18.5% of 27 pediatric patients with neurofi-
bromatosis type 1 had hypertension. Early diagnosis of
vascular affection in this predisposing conditionmay lead to
better outcomes.
CONCLUSION
DU imaging is a useful, cost-effective, noninvasive test
for RAS. It not only provides detection of stenosis and
occlusion in the renal arteries but also provides important
information about the renal parenchyma and surrounding
structures. A RAS prevalence of 22% and a renal artery
occlusion prevalence of 4% were identified by our study,
probably reflecting prevalence rates typical of an experi-
enced vascular laboratory at a university hospital. FMDwas
diagnosed in 10% of RAS patients. Our study also found
that about two of three patients diagnosed with RAS are
potential PTRAS candidates from the renal RI.
Incidental findings were detected in several patients.
About one of four of those incidental findings were signif-
icant enough to impact the management of the patient,
most importantly AAA and localized aortic stenosis.
Sixteen patients (5%) referred to our laboratory did not
have significant reasons related to renovascular disease.
A diagnostic yield of 22% was found among patients
who were receiving two antihypertensive medications, pos-
sibly indicating that the widely recognized suggestion of
referring patients for a DU examination to rule out RAS
when the blood pressure is uncontrolled with three or more
drugs may need to be revisited.
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